Sartorius (OTCMKTS:SARTF) Shares Gap Up – Still a Buy?

Sartorius (OTCMKTS:SARTFGet Free Report)’s stock price gapped up prior to trading on Thursday . The stock had previously closed at $196.0156, but opened at $212.80. Sartorius shares last traded at $212.80, with a volume of 1 shares changing hands.

Sartorius Stock Performance

The company has a quick ratio of 0.49, a current ratio of 0.95 and a debt-to-equity ratio of 0.89. The stock has a market cap of $7.28 billion, a P/E ratio of 98.98 and a beta of 0.98. The stock has a fifty day simple moving average of $213.89 and a 200-day simple moving average of $221.07.

About Sartorius

(Get Free Report)

Sartorius AG, trading in the U.S. over the counter under the symbol SARTF, is a Germany-based provider of laboratory and bioprocessing equipment for the pharmaceutical, biotechnology and research industries. The company is organized into two core divisions: Bioprocess Solutions, which focuses on single-use consumables, filtration technologies and upstream and downstream processing systems; and Lab Products & Services, which supplies laboratory instruments, consumables and services, including balances, pipettes, cell counting systems and water purification units.

The Bioprocess Solutions segment serves customers engaged in the development and manufacture of biopharmaceuticals, vaccines and advanced therapies.

Featured Articles

Receive News & Ratings for Sartorius Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sartorius and related companies with MarketBeat.com's FREE daily email newsletter.